Search Results

Five-Year PARTNER IIA Data Show Similar Outcomes for TAVR and SAVR in Intermediate-Risk Patients

September 28, 2019—The Cardiovascular Research Foundation (CRF) announced that the 5-year results from the PARTNER IIA trial were presented by Vinod H. Thourani, MD, at TCT 2019, the 31st annual Transcatheter Cardiovascular Therapeutics scientific symposium, which is sponsored by CRF and held September 25–29 in San Francisco, California.

JenaValve’s ALIGN-AR Pivotal Trial Results for Trilogy THV System Are Published

March 28, 2024—JenaValve Technology, Inc. announced the publication of results from the ALIGN-AR pivotal trial, which is a prospective, multicenter study evaluating the use of the company’s Trilogy transcatheter heart valve (THV) system in high-risk patients with symptomatic moderate-to-severe or severe aortic regurgitation (AR).

Pi-Cardia’s ShortCut Leaflet Modification Device for TAVR Used in First Commercial Procedures

March 3, 2025—Pi-Cardia Inc., an Israel-based developer of leaflet modification solutions for treating heart valves, announced the first commercial procedures with the company’s ShortCut leaflet modification device for enabling valve-in-valve transcatheter aortic valve replacement (TAVR) procedures in patients at risk of coronary obstruction.

CroíValve Begins TANDEM II Early Feasibility Study for Duo System to Treat TR

October 24, 2024—CroíValve announced the first patient treated with the Duo system as part of the TANDEM II early feasibility study in the United States.

MiRus’ Siegel TAVR Device FIH Experience Presented

June 6, 2024—MiRus, LLC, which is headquartered in Marietta, Georgia, announced that the first-in-human (FIH) procedures were performed with the company’s Siegel 8-F transcatheter aortic heart valve.

JenaValve Presents 2-Year ALIGN-AR Data for Trilogy THV

November 12, 2024—JenaValve Technology, Inc., announced 2-year follow up data from the ALIGN-AR pivotal trial of the company’s Trilogy transcatheter heart valve (THV) system.

Fifth Annual Heart Valve Disease Awareness Day Focuses on Health Disparities in Black Americans

February 22, 2021—More than 90 national organizations and thousands of patient advocates are recognizing the fifth anniversary of Heart Valve Disease Awareness Day held annually on February 22, announced the Alliance for Aging Research.